Financial reports
10-K
2022 FY
Annual report
13 Apr 23
NT 10-K
Notice of late annual filing
29 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
23 May 22
NT 10-Q
Notice of late quarterly filing
16 May 22
10-K
2021 FY
Annual report
8 Apr 22
NT 10-K
Notice of late annual filing
31 Mar 22
10-K/A
2020 FY
Annual report (amended)
20 Dec 21
10-Q
2021 Q3
Quarterly report
22 Nov 21
Current reports
8-K
Eucrates Biomedical Acquisition Corp. Announces Liquidation
11 Apr 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3 Apr 23
8-K
Entry into a Material Definitive Agreement
16 Feb 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8 Nov 22
8-K
Amendments to Articles of Incorporation or Bylaws
31 Oct 22
8-K
Submission of Matters to a Vote of Security Holders
24 Oct 22
8-K
Entry into a Material Definitive Agreement
26 Jan 22
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
19 Nov 21
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
21 Jun 21
8-K
Eucrates Biomedical Acquisition Corp. Receives Expected Notice from Nasdaq Regarding Delayed Quarterly Report
1 Jun 21
Registration and prospectus
15-12G
Securities registration termination
8 May 23
25-NSE
Exchange delisting
26 Apr 23
424B4
Prospectus supplement with pricing info
26 Oct 20
8-A12B
Registration of securities on exchange
22 Oct 20
S-1/A
IPO registration (amended)
21 Oct 20
S-1/A
IPO registration (amended)
15 Oct 20
S-1
IPO registration
6 Oct 20
DRS
Draft registration statement
2 Sep 20
Other
UPLOAD
Letter from SEC
12 Oct 22
CORRESP
Correspondence with SEC
5 Oct 22
UPLOAD
Letter from SEC
4 Oct 22
EFFECT
Notice of effectiveness
26 Oct 20
CERT
Certification of approval for exchange listing
22 Oct 20
CORRESP
Correspondence with SEC
21 Oct 20
CORRESP
Correspondence with SEC
21 Oct 20
CORRESP
Correspondence with SEC
21 Oct 20
UPLOAD
Letter from SEC
21 Oct 20
CORRESP
Correspondence with SEC
5 Oct 20
Ownership
SC 13G/A
Flynn James E
10 Feb 23
SC 13G
BlackRock Inc.
9 Nov 22
SC 13G
PRICE T ROWE ASSOCIATES INC /MD/
14 Feb 22
SC 13G/A
BlackRock Inc.
8 Feb 22
SC 13G
Eucrates LLC
12 Feb 21
SC 13G
BlackRock Inc.
8 Feb 21
4
PARAG SAXENA
27 Nov 20
4
STELIOS PAPADOPOULOS
27 Nov 20
4
Change in insider ownership
27 Nov 20
SC 13G
Flynn James E
30 Oct 20